Cendakimab (Anti-IL-13)
Product Specifications
CAS Number
2151032-62-9
Synonyms
RPC 4046; ABT 308; CC-93538
Target
Interleukins
Applications
Immunology & Inflammation
Additionnal Information
Cendakimab (anti-IL-13) is a humanized, recombinant monoclonal antibody against the interleukin-13 (IL-13) molecule with the potential to treat allergic/inflammatory diseases (e.g., asthma and eosinophilic esophagitis) . MW: 146.44 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
E-CL-H0167-01 24 Tests
Human PIIINP (N-Terminal Procollagen III Propeptide) CLIA Kit
Sign In for Pricing
View Details E-CL-H0167-02 48 Tests
Human PIIINP (N-Terminal Procollagen III Propeptide) CLIA Kit
Sign In for Pricing
View Details E-CL-H0167-03 96 Tests
Human PIIINP (N-Terminal Procollagen III Propeptide) CLIA Kit
Sign In for Pricing
View Details 
